Synthesis of Monomeric Derivatives To Probe Memoquin's Bivalent Interactions
2011 Bolognesi, Ml; Chiriano, G; Bartolini, M; Mancini, F; Bottegoni, G; Maestri, V; Czvitkovich, S; Windisch, M; Cavalli, A; Minarini, A; Rosini, M; Tumiatti, V; Andrisano, V; Melchiorre, C
Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase
2017 De Simone, A; Russo, D; Ruda, Gf; Micoli, A; Ferraro, M; Di Martino, Rmc; Ottonello, G; Summa, M; Armirotti, A; Bandiera, T; Cavalli, A; Bottegoni, G
Modeling lipid raft domains containing a mono-unsaturated phosphatidylethanolamine species
2015 Ferraro, M; Masetti, M; Recanatini, M; Cavalli, A; Bottegoni, G
The ligand binding mechanism to purine nucleoside phosphorylase elucidated via molecular dynamics and machine learning
2015 Decherchi, S; Berteotti, A; Bottegoni, G; Rocchia, W; Cavalli, A
Structure-Based Predictions of Activity Cliffs
2015 Husby, J; Bottegoni, G; Kufareva, I; Abagyan, R; Cavalli, A
Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies
2016 Gaspari, R; Rechlin, C; Heine, A; Bottegoni, G; Rocchia, W; Schwarz, D; Bomke, J; Gerber, Hd; Klebe, G; Cavalli, A
Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer's Disease
2012 Simoni, E; Daniele, S; Bottegoni, G; Pizzirani, D; Trincavelli, Ml; Goldoni, L; Tarozzo, G; Reggiani, A; Martini, C; Piomelli, D; Melchiorre, C; Rosini, M; Cavalli, A
Benzimidazole derivatives as kinase inhibitors
2014 Garuti, L; Roberti, M; Bottegoni, G.
Non-ATP Competitive Protein Kinase Inhibitors
2010 Garuti, L; Roberti, M; Bottegoni, G
Protein-ligand docking
2011 Bottegoni, G
Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity
2012 Scarpi, D; Cirelli, D; Matrone, C; Castronovo, G; Rosini, P; Occhiato, Eg; Romano, F; Bartali, L; Clemente, Am; Bottegoni, G; Cavalli, A; De Chiara, G; Bonini, P; Calissano, P; Palamara, At; Garaci, E; Torcia, Mg; Guarna, A; Cozzolino, F
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease
2015 Prati, Federica; DE SIMONE, Angela; Armirotti, Andrea; Summa, Maria; Pizzirani, Daniela; Scarpelli, Rita; Bertozzi, Sine Mandrup; Perez, Daniel I.; Andrisano, Vincenza; Perez Castillo, Ana; Monti, Barbara; Massenzio, Francesca; Polito, Letizia; Racchi, Marco; Sabatino, Piera; Bottegoni, Giovanni; Martinez, Ana; Cavalli, Andrea; Bolognesi, MARIA LAURA
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors
2016 DI MARTINO, RITA MARIA CONCETTA; DE SIMONE, Angela; Andrisano, Vincenza; Bisignano, Paola; Bisi, Alessandra; Gobbi, Silvia; Rampa, Angela; Fato, Romana; Bergamini, Christian; Perez, Daniel I.; Martinez, Ana; Bottegoni, Giovanni; Cavalli, Andrea; Belluti, Federica
Polo-like kinases inhibitors
2012 Garuti, L.; Roberti, M.; Bottegoni, G.
Dual inhibition of REV-ERB beta and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
2015 De Mei, C; Ercolani, L; Parodi, C; Veronesi, M; Lo Vecchio, C; Bottegoni, G; Torrente, E; Scarpelli, R; Marotta, R; Ruffili, R; Mattioli, M; Reggiani, A; Wade, M; Grimaldi, B
Small Molecule Aurora Kinases Inhibitors
2009 Garuti, L; Roberti, M; Bottegoni, G
SERAPhiC: A Benchmark for in Silico Fragment-Based Drug Design
2011 Favia, Ad; Bottegoni, G; Nobeli, I; Bisignano, P; Cavalli, A
Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3 beta Inhibitors
2015 Prati, F; De Simone, A; Bisignano, P; Armirotti, A; Summa, M; Pizzirani, D; Scarpelli, R; Perez, Di; Andrisano, V; Perez-Castillo, A; Monti, B; Massenzio, F; Polito, L; Racchi, M; Favia, Ad; Bottegoni, G; Martinez, A; Bolognesi, Ml; Cavalli, A
Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase
2014 De Simone, A; Ruda, Gf; Albani, C; Tarozzo, G; Bandiera, T; Piomelli, D; Cavalli, A; Bottegoni, G
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition
2019 Redenti, Sara; Marcovich, Irene; De Vita, Teresa; Pérez, Concepción; De Zorzi, Rita; Demitri, Nicola; Perez, Daniel I.; Bottegoni, Giovanni; Bisignano, Paola; Bissaro, Maicol; Moro, Stefano; Martinez, Ana; Storici, Paola; Spalluto, Giampiero; Cavalli, Andrea; Federico, Stephanie
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Synthesis of Monomeric Derivatives To Probe Memoquin's Bivalent Interactions | 1-gen-2011 | Bolognesi, Ml; Chiriano, G; Bartolini, M; Mancini, F; Bottegoni, G; Maestri, V; Czvitkovich, S; Windisch, M; Cavalli, A; Minarini, A; Rosini, M; Tumiatti, V; Andrisano, V; Melchiorre, C | |
| Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase | 1-gen-2017 | De Simone, A; Russo, D; Ruda, Gf; Micoli, A; Ferraro, M; Di Martino, Rmc; Ottonello, G; Summa, M; Armirotti, A; Bandiera, T; Cavalli, A; Bottegoni, G | |
| Modeling lipid raft domains containing a mono-unsaturated phosphatidylethanolamine species | 1-gen-2015 | Ferraro, M; Masetti, M; Recanatini, M; Cavalli, A; Bottegoni, G | |
| The ligand binding mechanism to purine nucleoside phosphorylase elucidated via molecular dynamics and machine learning | 1-gen-2015 | Decherchi, S; Berteotti, A; Bottegoni, G; Rocchia, W; Cavalli, A | |
| Structure-Based Predictions of Activity Cliffs | 1-gen-2015 | Husby, J; Bottegoni, G; Kufareva, I; Abagyan, R; Cavalli, A | |
| Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies | 1-gen-2016 | Gaspari, R; Rechlin, C; Heine, A; Bottegoni, G; Rocchia, W; Schwarz, D; Bomke, J; Gerber, Hd; Klebe, G; Cavalli, A | |
| Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer's Disease | 1-gen-2012 | Simoni, E; Daniele, S; Bottegoni, G; Pizzirani, D; Trincavelli, Ml; Goldoni, L; Tarozzo, G; Reggiani, A; Martini, C; Piomelli, D; Melchiorre, C; Rosini, M; Cavalli, A | |
| Benzimidazole derivatives as kinase inhibitors | 1-gen-2014 | Garuti, L; Roberti, M; Bottegoni, G. | |
| Non-ATP Competitive Protein Kinase Inhibitors | 1-gen-2010 | Garuti, L; Roberti, M; Bottegoni, G | |
| Protein-ligand docking | 1-gen-2011 | Bottegoni, G | |
| Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity | 1-gen-2012 | Scarpi, D; Cirelli, D; Matrone, C; Castronovo, G; Rosini, P; Occhiato, Eg; Romano, F; Bartali, L; Clemente, Am; Bottegoni, G; Cavalli, A; De Chiara, G; Bonini, P; Calissano, P; Palamara, At; Garaci, E; Torcia, Mg; Guarna, A; Cozzolino, F | |
| 3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease | 1-gen-2015 | Prati, Federica; DE SIMONE, Angela; Armirotti, Andrea; Summa, Maria; Pizzirani, Daniela; Scarpelli, Rita; Bertozzi, Sine Mandrup; Perez, Daniel I.; Andrisano, Vincenza; Perez Castillo, Ana; Monti, Barbara; Massenzio, Francesca; Polito, Letizia; Racchi, Marco; Sabatino, Piera; Bottegoni, Giovanni; Martinez, Ana; Cavalli, Andrea; Bolognesi, MARIA LAURA | |
| Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors | 1-gen-2016 | DI MARTINO, RITA MARIA CONCETTA; DE SIMONE, Angela; Andrisano, Vincenza; Bisignano, Paola; Bisi, Alessandra; Gobbi, Silvia; Rampa, Angela; Fato, Romana; Bergamini, Christian; Perez, Daniel I.; Martinez, Ana; Bottegoni, Giovanni; Cavalli, Andrea; Belluti, Federica | |
| Polo-like kinases inhibitors | 1-gen-2012 | Garuti, L.; Roberti, M.; Bottegoni, G. | |
| Dual inhibition of REV-ERB beta and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells | 1-gen-2015 | De Mei, C; Ercolani, L; Parodi, C; Veronesi, M; Lo Vecchio, C; Bottegoni, G; Torrente, E; Scarpelli, R; Marotta, R; Ruffili, R; Mattioli, M; Reggiani, A; Wade, M; Grimaldi, B | |
| Small Molecule Aurora Kinases Inhibitors | 1-gen-2009 | Garuti, L; Roberti, M; Bottegoni, G | |
| SERAPhiC: A Benchmark for in Silico Fragment-Based Drug Design | 1-gen-2011 | Favia, Ad; Bottegoni, G; Nobeli, I; Bisignano, P; Cavalli, A | |
| Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3 beta Inhibitors | 1-gen-2015 | Prati, F; De Simone, A; Bisignano, P; Armirotti, A; Summa, M; Pizzirani, D; Scarpelli, R; Perez, Di; Andrisano, V; Perez-Castillo, A; Monti, B; Massenzio, F; Polito, L; Racchi, M; Favia, Ad; Bottegoni, G; Martinez, A; Bolognesi, Ml; Cavalli, A | |
| Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase | 1-gen-2014 | De Simone, A; Ruda, Gf; Albani, C; Tarozzo, G; Bandiera, T; Piomelli, D; Cavalli, A; Bottegoni, G | |
| A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition | 1-gen-2019 | Redenti, Sara; Marcovich, Irene; De Vita, Teresa; Pérez, Concepción; De Zorzi, Rita; Demitri, Nicola; Perez, Daniel I.; Bottegoni, Giovanni; Bisignano, Paola; Bissaro, Maicol; Moro, Stefano; Martinez, Ana; Storici, Paola; Spalluto, Giampiero; Cavalli, Andrea; Federico, Stephanie |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su rivista23732
- 4 Contributo Atto di Convegno (ex...2
- 2 Contributo in Volume(ex Articol...1
Data di pubblicazione
- In corso di stampa47
- 2020 - 20265601
- 2010 - 20198105
- 2000 - 20095471
- 1990 - 19992897
- 1980 - 19891294
- 1970 - 1979283
- 1962 - 196936
Editore
- Verona : Euroconference48
- Societa Editrice il Mulino Spa:St...34
- Elsevier BV:PO Box 211, 1000 AE A...29
- Edizioni Quattroventi di Anna Ver...23
- Editrice Scuola Spa:via L Cadorna...20
- -Milano : Franco Angeli -Genova...15
- Katlenburg-Lindau : European Geop...15
- Franco Angeli Riviste SRL:viale M...14
- G. Giappichelli Editore, Torino13
- Il Mulino, Bologna13
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS226
- PHYSICAL REVIEW LETTERS199
- STUDI URBINATI DI SCIENZE GIURIDI...153
- PHYSICS LETTERS. SECTION B144
- STUDI URBINATI B, SCIENZE UMANE E...136
- CLASSICAL AND QUANTUM GRAVITY134
- PHYSICAL REVIEW D133
- PICCOLA IMPRESA113
- SOCIOLOGIA DELLA COMUNICAZIONE108
- PLOS ONE91
Serie
- WORKING PAPERS OLYMPUS1
Keyword
- Humans177
- Animals126
- COVID-19104
- Italy76
- Male72
- Female57
- Gravitational Waves57
- LIGO53
- Mice52
- inflammation49
Lingua
- eng11738
- ita6665
- fre219
- spa151
- ger101
- lat40
- por30
- rus28
- grc11
- ara6
Accesso al fulltext
- no fulltext20959
- open1823
- restricted564
- partially open337
- reserved40
- embargoed10
- mixed1